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Abstract 
Neuroblastoma is an embryonic malignancy arising from neuroblasts. The mechanisms that 
regulate the origination of neuroblastoma are still not very clear. In this study, we revealed 
that  6-bromoindirubin  3’-oxime  (BIO),  a  specific  GSK-3  inhibitor,  promoted  N2A 
cells-derived neurons to become tumor-like neuroblasts. Moreover, constitutively activated 
-catenin (S33Y) also promoted this process, whereas, silencing endogenous expression of 
-catenin abolished BIO-induced effects. These results implicated the potential relationship 
between the Wnt/-catenin signaling and neuroblastoma formation. Indeed, we found that the 
amount of -catenin in nucleus, which indicated the activation of Wnt/-catnin signaling, was 
accumulated in human neuroblastoma specimens and positively correlated with clinical risk of 
neuroblastoma. These results give us a new sight into the neuroblastoma initiation and 
progression, and provide a potential drug target for neuroblastoma treatment. 
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Introduction 
Neural development is a strictly controlled pro-
cess that integrates proliferation, differentiation, and 
programmed  cell  death  or  apoptosis  [1].  Abnormal 
neural  development  may  lead  to  emotional,  behav-
ioral  and  learning  problems  in  children,  even  the 
growth of neural tumors [2]. Neuroblastoma, an em-
bryonic  malignancy  of  the  nervous  system  arising 
from neuroblasts [3], is the most common extracranial 
solid tumor of childhood. Although substantial pro-
gress  has  been  made  in  identifying  neuroblastoma 
specific molecular targets, it still remains a complex 
medical  challenge  to  understand  the  molecular 
mechanism  of  neuroblastoma  initiation,  differentia-
tion and regression. Recently, studies have focused on 
the molecular link between neural development and 
the genesis of neuroblastoma. 
Wnt/-catenin signaling is correlated with  nu-
merous cancers, such as intestine, breast, prostate and 
lung cancers. Dysregulation of this pathway plays an 
important  role  in  a  number  of  adult  and  pediatric 
tumors,  which  indicates  the  important  role  of 
Wnt/-catenin  signaling  pathway  in  tumors  [4].  In 
addition,  canonical  Wnt  signaling  through  the 
-catenin/TCF/LEF  transcription  complex  has  been 
demonstrated  to  play  a  central  role  in  neural  crest 
induction [5] and progenitor cell fate determination in 
both embryonic and adult stem cells [6-7]. It has been 
reported that Wnt/-catenin signaling could promote 
neural stem cell (NSC) proliferation [8] and prevent 
neuronal differentiation [9], even reprogram somatic 
cells  into  pluripotent  cells  [10-11].  Although 
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Wnt/-catenin signaling plays essential roles in many 
tumors and is involved in neural development, its role 
in neuroblastoma has not been well explored.  
In  this  study,  we  investigated  the  role  of 
Wnt/-catenin in modulation of cellular plasticity of 
the N2A cells-derived neurons and its possible func-
tions in origination of neuroblastoma. We found that 
6-bromoindirubin  3’-oxime  (BIO),  a  specific  GSK-3 
inhibitor, could promote N2A cells-derived neurons 
to become tumor-like neuroblasts according to mor-
phological  observation  and  marker  staining.  Con-
sistently,  we  showed  that  constitutive  activated 
-catenin had the similar function. Moreover, the di-
rect target genes of Wnt/-catenin signaling includ-
ing c-Myc and CyclinD1, as well as Id2 and Id3 were 
found to be greatly up-regulated which suggested the 
possible role of these genes during this cellular plas-
ticity  change  process.  In  human  neuroblastoma 
specimens,  we  found  that  the  amount  of  activated 
-catenin in nucleus was up-regulated significantly in 
pace with  clinical neuroblastoma  risk. These results 
suggest the important role of Wnt/-catenin signaling 
in modulation of cellular plasticity and possible func-
tions in neuroblastoma origination.  
Materials and methods 
Human tissue acquisition 
This  study,  approved  by  the  Research  Ethics 
Board  of  the  Third  Affiliated  Hospital  of  Soochow 
University, was conducted on 12 patients undergoing 
surgery  between  1990  and  2000,  including  3  stro-
ma-poor  neuroblastomas,  5  stroma-rich  neuroblas-
tomas and 4 mixed histology with stroma-poor and 
stroma-rich  regions.  The  tissues  were  embedded  in 
paraffin  for  pathology  diagnosis  after  surgery  and 
were identified by Department of Pathology of Third 
Affiliated  Hospital  of  Soochow  University. Written 
informed consent was obtained from all patients or 
their representatives. 
Cell culture and cell counting 
Mouse N2A neuroblastoma cells were purchased 
from ATCC. N2A cells were cultured in Dulbecco’s 
modified Eagle’s medium  (DMEM), containing 10% 
FBS  (Invitrogen,  Carlsbad,  CA)  and  penicil-
lin/streptomycin (100 U/ml and 100 mg/ml, respec-
tively) at 37oC and 5%CO2.  
For  the  induction  of  neuronal  differentiation, 
N2A cells were plated at a density of 100 cells/mm2. 
After  overnight  incubation,  cells  were  cultured  in 
N2B27  medium  for  96  hours.  The  medium  was  re-
freshed  every  24  hours.  Cells  having  one  or  more 
neurites of a length more than twice the diameter of 
the  cell  body  were  defined  as  post-mitotic  neurons 
[12]. To quantify cell differentiation, eight randomly 
chosen  fields  from  duplicate  wells  were  photo-
graphed at each time point, and at least 800 cells were 
counted.  Average  percentage  of  differentiated  cells 
was  calculated  from  two  to  three  independent  ex-
periments. BIO used in experiments was bought from 
Calbiochem (cat. no. 361550-1MG), and DKK1 protein 
was from R&D company (cat. no.1765-DK-010). 
Cell transfection 
N2A cells were cultured in N2B27 medium for 96 
hours and then transfected with pCAGGS-IRES-GFP, 
pCAGGS-S33Y--catenin-IRES-GFP  plasmid,  ctrl 
siRNA  (target  sequence:  5’  dTdTCdTCCGAAC-
GdTGdTCACGdTdTdT3’)  or  -catenin-specific  siR-
NA  (target  sequence:  5’  AC-
CATGCAGAATACAAATGATdTdT3’)  by  lipofect-
mina 2000 (Invitrogen, Carlsbad, CA, USA) according 
to  the  manufacturer’s  instructions.  Cells  were  har-
vested at 24 hours post transfection and prepared for 
immunofluorescence. 
Immunofluorescence 
Cells were fixed with 4% paraformaldehyde in 
PBS,  and  permeabilized  with  Triton 
X-100/Tris-buffered  saline.  For  tissues,  the  paraffin 
was  removed  from  human  tissue  sections  with  a 
standard  procedure.  Heat-induced  antigen  retrieval 
procedure was conducted at 92
oC for 20 minutes with 
0.01  M  citrate  buffer  (PH  6.0).  Then  the  following 
antibodies  were  used:  Monoclonal,  anti-Tuj1  (1:500, 
Covance),  anti-Nestin  (1:200,  BD  Pharmingen),  an-
ti--catenin (1:500, BD Pharmingen). Secondary anti-
body:  anti-mouse-Cy3  (1:500,  Jackson  Immu-
noResearch  Laboratories)  was  used  to  visualize  im-
munostaining. The images were taken with Olympus 
microscopy or Leica confocal microscopy SP2. Quan-
tification  of  percentage  of  cells  immunoreactive  for 
Tuj1 (neuronal class III β-Tubulin, a neural stem cell 
marker) or Nestin antigens was determined by cap-
turing  images  random  fields.  DAPI  staining  nuclei 
and cells positive for the Tuj1, Nestin were counted. 
Western blot 
For  cell  samples,  plasmids  (GFP  or 
S33Y--catenin)  or  siRNAs  (ctrl  siRNA  or  -catenin 
siRNA)-transfected  or  BIO-treated  N2A  cells  were 
subjected  for  cytosol  and  nucleus  protein  analysis. 
The detailed methods were described previously [13]. 
For  tissue  samples,  cytosol  and  nucleus  proteins  of 
each sample were subjected to Western blot analysis 
with the similar method. The cytosol or nucleus pro-
tein levels were calculated with software Image J, and Int. J. Biol. Sci. 2012, 8 
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the relative expression levels of -catenin proteins in 
cytosol  or  nucleus  were  analyzed.  Antibodies  in-
cluding -catenin (BD Biosciences), H3-histone (Sig-
ma) and -actin (Cell Signaling) were used. 
Luciferase assay 
After N2A cell differentiation in N2B27 medium 
for 96 hours, TopFlash or FopFlash plasmid together 
with  prl-tk  plasmid  were  transfected  into  cells,  ac-
companying with DMSO, BIO or 10%FBS treatment. 
The  cells  were  harvested  for  luciferase  assay  at  24 
hours  after  transfection  with  previously  reported 
method [14]. 
Cell cycle analysis 
After differentiated for 96 hours, N2A cells were 
treated with BIO for 24 hours. The cells were collected 
and washed with PBS, and then resuspended in 1ml 
DNA  staining  solution  (20mg/ml  of  Propidium  Io-
dide (PI) and 100mg/ml of RnaseA in PBS) for 30min 
on ice. DNA content was analyzed by FACS (Becton 
Dickinson, USA). The resulting DNA histograms were 
quantified using the Cell Quest Pro software. 
Real-time PCR 
Total  mRNA  was  extracted  from  cells  using 
Trizol  reagent  (Invitrogen,  Carlsbad,  CA,  USA)  ac-
cording  to  the  manufacturer’s  instructions.  The  re-
verse transcription was conducted with 2g of total 
RNA using AMV reverse transcriptase (TaKaRa, To-
kyo, Japan). Real-time PCR was performed using an 
Applied Biosystems 7500 Sequence Detection system 
(Applied  Biosystems,  Foster  city,  CA,  USA)  by 
standardized protocol. All reactions were run in trip-
licate and GAPDH was selected as an internal control. 
The relative amount of each mRNA to internal control 
GAPDH was calculated by using the equation 2-△CT, in 
which △CT = CT mRNA - CT GAPDH. The primers for re-
al-time PCR are available upon request.  
Statistics 
Each  experiment  was  repeated  at  least  three 
times, and similar results were obtained. Data were 
presented  as  mean  ±  s.d.  Comparisons  were  per-
formed using student’s t-test. Differences were con-
sidered statistically significant at * p<0.05. 
Results and Discussion 
N2A cells were typical model for neuronal dif-
ferentiation  in  vitro  [15].  In  the  induction  medium 
N2B27,  N2A  cells  could  differentiate  into  neurons 
with neurites (Fig. 1Aa-b). In our study, we found that 
the  outgrowth  of  neurites  and  the  typical  neuronal 
phenotype of neurons that differentiated from N2A 
cells disappeared after re-feeding with 10% FBS (Fig. 
1Ac), suggesting that some factors in the serum might 
cause  the  change  of  the  cellular  plasticity  of  N2A 
cells-derived neurons. 
Considering  the  close  relationship  between 
Wnt/-catenin signaling and neural development, we 
wondered whether Wnt/-catenin pathway was in-
volved in this process. Indeed, we found that DKK1 
protein  as  an  inhibitor  of  Wnt/-catenin  pathway 
could  block  the  FBS-induced  change  of  the  cellular 
plasticity of N2A cell-derived neurons (Fig. 1B). Fur-
thermore, we found that Wnt/-catenin signaling was 
activated by adding 10% FBS as the luciferase activity 
of TopFlash was increased (Supplementary Material: 
Fig. S1), suggesting a potential role of Wnt pathway in 
this  process.  Therefore,  we  used  BIO,  a  glycogen 
synthase  kinase-3  (GSK3)  inhibitor,  which  could 
stabilize -catenin protein by preventing its degrada-
tion,  to  further  examine  the  effects  of  activating 
Wnt/-catenin pathway. The results showed that BIO 
could significantly stimulate Wnt/-catenin pathway 
activity  as  indicated  by  the  luciferase  activity  and 
protein levels of -catenin in nuclei (Supplementary 
Material: Fig. S1 and Supplementary Material: Fig. S2 
(lanes 1 and 2)).  With different doses of BIO (2M, 
5M and 10M), we found that neuronal phenotypes 
of N2A cells-derived neurons were gradually changed 
as doses of BIO increased (Fig. 1C). We also noticed 
that some cells presented cell death-like phenotype as 
nucleus was broken down when high doses of BIO 
(5M and 10M) were added (Fig. 1Cc-d). Therefore, 
we  used  2M  BIO  in  our  following  experiments. 
These results showed that the N2A cell-derived neu-
ron cell fate change was possibly dependent on BIO 
activation.  
In  order  to  confirm  whether  this  phenotype 
change was caused by the activation of Wnt/-catenin 
pathway,  constitutively  activated  -catenin 
(S33Y--catenin)  was  transfected  into  neurons  that 
induced  from  N2A  cells  to  activate  Wnt/-catenin 
signaling. The results showed that the protein levels 
of -catenin were increased both in cytosol and nuclei 
after  S33Y--catenin  transfection  (lanes  3  and  4  in 
Supplementary Material: Fig. S2), as a result, neurites 
and  the  neuronal  phenotypes  of  S33Y--catenin 
highly expressed cells were significantly disappeared 
compared  with  the  phenotypes  of  GFP-transfected 
cells (Fig. 2A). Quantitative assessment of neuron-like 
cells  and  neuroblast-like  cells  by  cell  morphology 
showed  that  S33Y--catenin  significantly  decreased 
the ratio of neuron-like cells from 46% to 18%, and 
increased the ratio of neuroblast-like cells from 54% to 
82%  (Fig.  2B).  To  analyze  whether  endogenous Int. J. Biol. Sci. 2012, 8 
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-catenin is responsible for BIO-induced effects,  we 
employed -catenin siRNA and demonstrated its effi-
ciency (lanes 5 and 6 in Supplementary Material: Fig. 
S2). The results showed that the effects of BIO which 
promoted N2A cell-derived neurons to become neu-
roblastoma-like  cells  were  significantly  decreased 
when the expression of -catenin was silenced (Figs. 
2C and 2D), which strongly suggest that endogenous 
-catenin mediated the role of BIO. Together with the 
above findings, these results suggest that activation of 
Wnt/-catenin pathway induced by BIO or constitu-
tive  activated  -catenin  is  responsible  for  N2A 
cell-derived neuron cell fate change.  
 
 
 
Fig.1 BIO promotes N2A cell-derived neuron morphological changes. (A) N2A cells were induced to differentiate into neurons as 
previously described (b). Four days later, N2B27 medium was replaced by 10% FBS (c). The induced neurite outgrowth was shown by 
brightfield images. Sclar bar = 200m. (B) After induction of N2A cells for 4 days, the cells were treated with 10% FBS (a) or 10% 
FBS+DKK1 (100ng/ml) (b). Sclar bar = 100m. (C) After induction of N2A cells for 4 days, the cells were treated with DMSO (a), 2M (b), 
5M (c) or 10M (d) BIO for 12 hours, respectively. Sclar bar = 100m Int. J. Biol. Sci. 2012, 8 
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Fig.2 Constitutive activated -catenin modulates N2A cell-derived neuron cell fate. (A) After induction of N2A cells for 4 days, the 
morphology of GFP transfected cells (a, green) and S33Y--catenin transfected cells (c, green) were indicated by white arrow in cor-
responding immunofluorescence images and phase images. Sclar bar = 100m. (B) Quantitative assessment of neuron-like cells and 
neuroblastoma-like cells by cell morphology in GFP transfected cells and S33Y--catenin transfected cells. (C) After induction of N2A cells 
for 4 days, the morphology of GFP+Ctrl siRNA -transfected cells (a, green) and GFP+-catenin siRNA-transfected cells (c, green) were 
indicated by white arrow in corresponding immunofluorescence images and phase images. Sclar bar = 100m. (D) Quantitative as-
sessment of neuron-like cells and neuroblastoma-like cells by cell morphology in GFP+Ctrl siRNA and GFP+-catenin siRNA-transfected 
cells. 
 
To further confirm that N2A cells-derived neu-
rons  were  changed  as  tumor-like  neuroblasts  after 
activation  of  Wnt/-catenin  pathway  by  BIO,  we 
checked the expression of neuroblast marker Nestin 
and  neuron  marker  Tuj1.  The  results  showed  that 
most  cells  were  Nestin  negative  and  Tuj1  positive 
neurons after induction of N2A cells in differentiation 
medium (Fig. 3A). After adding 2M BIO, the number 
of  Nestin  positive  neuroblasts  was  significantly  in-
creased, while the number of Tuj1 positive neurons 
was  sharply  reduced  (Fig.  3A).  Statistical  analysis 
showed that Nestin positive NSCs raised from 19.5% 
to 71.4%, while Tuj1 positive neurons decreased from 
62.3% to 25.4% (Fig. 3B), which suggested that BIO 
could promote neurons into tumor-like neuroblasts. 
Real-time PCR was also used to test the expression 
changes of neuroblast markers such as Sox2 and Nes-
tin during this process. We found that the expression 
of Sox2 and Nestin were significantly up-regulated for 
about 30 and 10 folds, respectively (Fig. 3C). We also 
examined the number of cells that reentered into cell 
cycle and found that the number of cells in cell cycle 
was  significantly  increased  with  BIO  stimulation 
(Supplementary Material: Fig. S3). These data further 
supported the observation that neurons were changed 
into  neuroblasts  by  BIO-activated  Wnt/-catenin 
pathway.  In  previous  studies,  the  Wnt  signaling 
pathway  has  been  demonstrated  to  participate  in Int. J. Biol. Sci. 2012, 8 
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many normal and abnormal biological processes [16]. 
During neural development, Wnt/β-catenin signaling 
pathway takes part in neural crest formation [17-18], 
neuronal differentiation as well as neurite outgrowth 
during cultured early-born hippocampus neuron dif-
ferentiation [19-20]. In this study, we first promoted 
N2A cells to differentiate into neurons (differentiation 
for  4  days  in  serum-free  medium),  then  activated 
Wnt/-catenin  signaling  in  these  N2A  cell-derived 
neurons  and  found  that  activated  Wnt/-catenin 
signaling forced these N2A cell-differentiated neurons 
to  become  tumor-like  neuroblasts  (Figs.  1-3).  Com-
bining these results with previous reports [19-20], we 
suggest  that  Wnt/-catenin  signaling  have  distinct 
functions in different processes and different physio-
logical  conditions  of  neuronal  differentiating.  Here, 
our results reveal a novel function of Wnt/-catenin 
pathway in N2A cell-derived neuron cell fate modu-
lation  and  imply  the  relationship  of 
-catenin-mediated  activation  and  neuroblastoma 
formation.  
 
Fig.3 BIO promotes N2A cell-derived neurons back into tumor-like neuroblasts and up-regulates Id genes during this process. (A) 
Immunofluorescent staining of N2A cells and 2M BIO treated N2A cells with anti-Nestin antibody (a and e, red), anti-Tuj1 antibody (c 
and g, red) and DAPI (b, d, f and h, blue). Scale bar= 200 m. (B) Quantitative assessment of Nestin positive and Tuj1 positive cells in 
control and BIO-treated N2A cells. (C) Relative mRNA expression level of NSC marker Sox2 and Nestin in control and BIO-treated N2A 
cells. (D) Relative mRNA expression level of c-Myc and CyclinD1 in control and BIO-treated N2A cells. (E) Relative mRNA expression level 
of Ids in control and BIO-treated N2A cells. Int. J. Biol. Sci. 2012, 8 
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Fig.4 Activated -catenin expression in clinical variants of human neuroblastoma. (A) Representative data of tissue sample Western blot. 
The expression of -catenin protein in cytosol and nuclei was indicated. -actin protein was used as a positive control for cytosol and 
negative control for nuclei, and H3-histone was used as a positive control for nuclei and negative control for cytosol. The symbols (1, 2, 
3) indicated low, intermediate and high risk neuroblastoma tissue samples, respectively. (B) Quantitative assessment of the relative 
-catenin protein levels of all tissue samples with Image J. The relative amount of -catenin protein in cytosol and nuclei was normalized 
with -actin and H3-histone, respectively. (C) (a-c) 3 stroma-poor deteriorated neuroblastomas with a favorable clinical outcome (low 
risk, a), 4 mixed histology with stroma-poor and stroma-rich regions (intermediate risk, b) and 5 stroma-rich neuroblastomas with poor 
outcome (high risk, c) were checked for their nucleus -catenin levels (d for low risk, e for intermediate risk and f for high risk). (d-l) The 
level of -catenin in nucleus was higher in high risk neuroblastomas than in intermediate risk neuroblastomas and low risk neuroblastomas. 
Scale bar= 50 m for a-c, =25 m for d-l. 
 
To  explore  the  molecular  mechanisms,  we  ex-
amined  the  expression  pattern  of  the  downstream 
targets of Wnt/-catenin pathway, which may be in-
volved in  modulation of cellular plasticity. We first 
checked  the  direct  target  genes  of  Wnt/-catenin 
pathway such as c-Myc and CyclinD1 and found that 
both genes are up-regulated upon Wnt signaling ac-
tivation (Fig. 3D). In addition, we also observed that 
Id family genes, including Id2, Id3 and Id4 had a sig-
nificant change during this process. Id2 and Id3 were 
significantly  up-regulated  (Fig.  3E).  c-Myc  and  Cy-
clinD1 proteins are important for cancer cell prolifer-Int. J. Biol. Sci. 2012, 8 
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ation [21] while Id proteins are involved in initiation 
and  progression  processes  of  many  human  tumors 
including  endometrial  carcinoma,  melanoma,  pan-
creatic  carcinoma,  head  and  neck  cancers,  and  me-
dullary thyroid carcinoma [22]. Studies found that Id 
proteins could transfer the phenotypic traits of em-
bryonic stem cells to cancer cells [23-25], and mediate 
tumor reinitiation during tumor metastasis [26]. Our 
results showed that c-Myc and CyclinD1, as well as Id2 
and  Id3  were  significantly  up-regulated  by 
Wnt/-catenin  signaling  when  N2A  cell-derived 
neurons  were  forced  to  become  tumor-like  neuro-
blasts (Figs. 3D and 3E), suggesting that Id genes may 
mediate  the  function  of  Wnt/-catenin  signaling  in 
neuroblastoma  initiation,  and  c-Myc  and  CyclinD1 
play crucial role in neuroblastoma proliferation. 
Considering  -catenin  could  promote  N2A 
cell-derived  neurons  to  become  tumor-like  neuro-
blasts, it  is reasoned to  propose  that  the activity of 
Wnt/-catenin pathway may be associated with hu-
man neuroblastoma progression in situ. We examined 
the -catenin protein levels in nucleus of 12 human 
neuroblastomas,  5  stroma-rich  neuroblastomas  with 
poor  outcome  (high  risk),  4  mixed  histology  with 
stroma-poor  and  stroma-rich  regions  (intermediate 
risk),  and  3  stroma-poor  neuroblastomas  with  a  fa-
vorable clinical outcome (low risk). We analyzed all 
the tissue samples we have, and presented the repre-
sentative Western blot data to show that the levels of 
-catenin protein in cytosol and nucleus were gradu-
ally  up-regulated  as  the  risk  of  neuroblastomas  in-
creased (Fig. 4A). Statistical analysis of all the Western 
blot data further supported our notion that activated 
-catenin  protein  levels  in  nucleus  were  correlated 
with neuroblastoma clinical outcome (Fig. 4B). Con-
sistently,  the  immunofluorescence  experiment  also 
showed that the level of -catenin in nucleus was ev-
idently  up-regulated  in  both  intermediate  risk  and 
high  risk  neuroblastomas  compared  with  low  risk 
neuroblastomas (Fig. 4Cd-l). Thus, the data suggest 
that the stronger the -catenin expressed in nucleus, 
the higher risk of neuroblastoma, and the poorer the 
prognosis  is.  Taken  the  above  results  together,  we 
could refer that -catenin in nucleus is one of the key 
factors in determining neuroblastoma carcinogenesis. 
Consistent with our results, Wnt/-catenin signaling 
inhibitors  such  as  DDK1  are  found  to  be  effective 
methods to treat neuroblastoma  in vitro [27]. There-
fore,  these  studies  suggest  a  potential  key  role  of 
-catenin in  human neuroblastoma progression  and 
prognosis  which  may  further  provide  us  a  new  in-
sight into the cure of neuroblastoma. 
Conclusion 
In this study, we revealed that BIO (a  specific 
GSK-3  inhibitor)  or  activated  -catenin  could  pro-
mote N2A cell-derived neurons to become tumor-like 
neuroblasts  which  implicated the potential relation-
ship between the Wnt/-catenin signaling and neu-
roblastoma  formation.  Furthermore,  we  found  that 
the amount of -catenin in nucleus was accumulated 
in  human  neuroblastoma  specimens  and  positively 
correlated with clinical risk of neuroblastoma. Taken 
together,  these  results  may  provide  us  a  new  sight 
into  the  initiation,  progression  and  cure  of  neuro-
blastoma. 
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